AwardTape · Defense awards · Professional services · Studies and analysis · HT942524P0103
HT942524P0103: $120K purchase order to Genovac Antibody Discovery LLC
Genovac Antibody Discovery LLC holds a purchase order from Defense Health Agency with $120K obligated since Oct 2023, against a ceiling of $180K. Latest action Apr 8, 2026.
Human monoclonal antibody development
| PIID | HT942524P0103 |
|---|---|
| Type | purchase order |
| Company | Genovac Antibody Discovery LLC |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Professional services · Studies and analysis |
| PSC | B537 SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $120K |
| Total obligated (lifetime) | $120K |
| Ceiling (base and all options) | $180K |
| Base date | Sep 6, 2024 |
| Latest action | Apr 8, 2026 |
| End date | Jun 24, 2026 |
| Actions since Oct 2023 | 5 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial